Paradigm BiopharmaceuticalsPAR 
$0.16-4.08%24h
-4.08%24h
Global rank24580
Market cap$46.05M
Change 7d2.17%
YTD Performance-46.59%
SP500 benchmarkUnderperform
P/E-0.89
P/S1455.83
Revenue$31.63K
Earnings-$35.12M
Dividend yield-
Main Sector
Healthcare
EPS for Paradigm Biopharmaceuticals (PAR)
Paradigm Biopharmaceuticals has an EPS of $-0.179163. In 2022, the company made an earnings per share (EPS) of $-0.162901. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for PAR
-
Value:-
EPS history for Paradigm Biopharmaceuticals from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | -$0.179163 | 9.98% |
| 2022 | -$0.162901 | 0.78% |
| 2021 | -$0.161645 | - |
View the highest EPS stocks
